-transparent.png){kind=logo}
BACKGROUND Growth hormone (GH) regulates the immune and metabolic systems; however, the effects of GH on the functions and cell death of polymorphonuclear neutrophils (PMNs) are not well understood. Therefore, this study was designed to investigate the effects of GH on PMN apoptosis, reactive oxygen intermediates (ROI) production, CD16, and Fas expression. We also investigated the effects of GH on the functions of other circulating leukocytes (ie, monocytes and lymphocytes). METHODS Venous blood was collected from healthy volunteers. Whole blood was washed and pretreated with GH (0 or 100 ng/mL) for 3 hours and then cultured for 0, 4, or 12 hours. PMNs in washed whole blood were analyzed by flow cytometry for cell death, phorbol myristate acetate-stimulated ROI production, CD16, and Fas expression at each time point. Morphologic features also were assessed. PMN apoptosis was confirmed by chromatin staining and DNA gel electrophoresis. RESULTS GH inhibited PMN apoptosis at 12 hours of culture. GH enhanced ROI production by PMNs and monocytes throughout the 12-hour culture but had no effects on CD16 expression on PMNs. Furthermore, GH decreased Fas expression on PMNs at 4 hours of culture. However, there were no effects of GH on apoptosis of monocytes or lymphocytes for the duration of this experiment. CONCLUSIONS GH pretreatment down-regulates Fas expression on PMNs, inhibits apoptosis, and up-regulates ROI production. GH pretreatment also increases monocyte ROI production. Although activated PMNs have potentially harmful aspects, our results suggest that GH may improve host defense, mainly through enhancement of the PMN functional life span.
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
October 2002,
Inflammation,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
May 1994,
Research communications in chemical pathology and pharmacology,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
April 1996,
Anesthesia and analgesia,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
September 2004,
European journal of pharmacology,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
February 2012,
Nature immunology,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
October 1984,
Bollettino della Societa italiana di biologia sperimentale,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
January 1996,
The Journal of biological chemistry,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
November 1999,
Critical care medicine,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
April 1985,
The Biochemical journal,
T Matsuda, and
H Saito, and
T Inoue, and
K Fukatsu, and
I Han, and
S Furukawa, and
S Ikeda, and
T Muto
July 2000,
Journal of leukocyte biology,
